GLP-1 medications are changing more than appetite.
As uptake grows across the UK, their impact is beginning to show up in everyday life, not just in clinical outcomes, but in shopping baskets, spending habits and lifestyle priorities.
We wanted to understand what that shift really looks like in practice.
So we reached out to our in-house community of over 250,000 active participants and invited people currently taking GLP-1 medications to take part in a short pulse survey. We asked how their habits are changing, from food and fitness to spending and brand choices.
In the full report that you can download at the bottom of this page, we explore:
For businesses operating in food, drink, retail or health, the implications are hard to ignore.
GLP-1 is influencing behaviour in subtle but commercially meaningful ways, and the brands that adapt early are likely to stay relevant.
